Anthony W. Opipari

CIK: 0002131341

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)1 (20.0%)

Derivative conversions

Awards (A)2 (40.0%)

Compensation grants

Other (G, F, J, C, D, …)2 (40.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

ODTX

Odyssey Therapeutics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (5 total)

ODTX
Odyssey Therapeutics, Inc.
May 11, 2026
Conversion(C)
Direct
7K shares-
ODTX
Odyssey Therapeutics, Inc.
May 11, 2026
Exercise(M)
Direct
541 shares-
ODTX
Odyssey Therapeutics, Inc.
May 11, 2026
Tax Payment(F)
Direct
4 shares at avg. $18.00$72
ODTX
Odyssey Therapeutics, Inc.
May 7, 2026
Award(A)
Stock Option (Right to Buy)
Direct
250.2K shares-
ODTX
Odyssey Therapeutics, Inc.
May 7, 2026
Award(A)
Stock Option (Right to Buy)
Direct
27.8K shares-

		Type	Shares	Price		Ownership
May 11, 2026	ODTX Odyssey Therapeutics, Inc.	Conversion(C)	6,965	-	$0	Direct
May 11, 2026	ODTX Odyssey Therapeutics, Inc.	Exercise(M)	541	-	$0	Direct
May 11, 2026	ODTX Odyssey Therapeutics, Inc.	Tax Payment(F)	4	$18.00	$72	Direct
May 7, 2026	ODTX Odyssey Therapeutics, Inc.	Award(A) Stock Option (Right to Buy)	250,203	-	-	Direct
May 7, 2026	ODTX Odyssey Therapeutics, Inc.	Award(A) Stock Option (Right to Buy)	27,777	-	-	Direct

1-5 of 5 transactions

About Opipari Anthony W.

Opipari Anthony W. (SEC CIK 0002131341) files insider reports with the SEC as Officer of Odyssey Therapeutics, Inc. (ODTX).

Signal8 holds 2 ownership filings by Opipari Anthony W. (1 Form 3, 1 Form 4), filed between May 7, 2026 and May 11, 2026. Those filings report 5 transactions, from May 7, 2026 to May 11, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Opipari Anthony W.'s filings is in BOSTON, MA.

Recent filings by Opipari Anthony W.

May 11, 2026: Conversion of ODTX shares (Form 4, code C).
May 11, 2026: Option exercise of ODTX shares (Form 4, code M).
May 11, 2026: Tax withholding of ODTX shares (Form 4, code F).
May 7, 2026: Grants or awards of ODTX derivative securities (2 lines, Form 4, code A).

Other insiders filing for Odyssey Therapeutics, Inc. (ODTX)

TPG GP A, LLC, Officer
Dimension Capital II, L.P., Director
SR ONE CAPITAL MANAGEMENT, LLC, 10% Owner
LEIDEN JEFFREY M, Director
Haas Jason, Chief Financial Officer
Li Nan (LN), Director

How to read Form 4 transaction codes